fluconazole has been researched along with Miosis in 1 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Miosis: Pupillary constriction. This may result from congenital absence of the dilatator pupillary muscle, defective sympathetic innervation, or irritation of the CONJUNCTIVA or CORNEA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This investigation determined the ability of alfentanil miosis and single-point concentrations to detect various degrees of CYP3A inhibition." | 9.11 | Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimally invasive and noninvasive probes for hepatic and first-pass CYP3A activity. ( Hoffer, C; Kharasch, ED; Sheffels, P; Walker, A, 2005) |
| "This investigation determined the ability of alfentanil miosis and single-point concentrations to detect various degrees of CYP3A inhibition." | 5.11 | Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimally invasive and noninvasive probes for hepatic and first-pass CYP3A activity. ( Hoffer, C; Kharasch, ED; Sheffels, P; Walker, A, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kharasch, ED | 1 |
| Walker, A | 1 |
| Hoffer, C | 1 |
| Sheffels, P | 1 |
1 trial available for fluconazole and Miosis
| Article | Year |
|---|---|
Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimally invasive and noninvasive probes for hepatic and first-pass CYP3A activity.
Topics: Administration, Oral; Adult; Alfentanil; Analgesics, Opioid; Area Under Curve; Cross-Over Studies; C | 2005 |